Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Preventive Medicine
|
March 8, 2021
Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis
Allison Portnoy, Kine Pedersen, Lill Trogstad, et al.
Journal of the National Cancer Institute
|
February 6, 2025
Impact of screening for human papillomavirus-positive oropharyngeal cancers: a microsimulation-based modeling study
Rebecca Landy, Gregory W Haber, Barry I Graubard, et al.
The Lancet. Oncology
|
June 2, 2019
Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact
Danielle Rodin, Emily A Burger, Rifat Atun, et al.
International Journal of Cancer
|
December 19, 2025
Cost-effectiveness of low-dose CT lung cancer screening among individuals that have ever smoked in Norway: A model-based analysis using NELSON trial criteria and outcomes
Yancy S Wu, Natalia Kunst, Dávid M Győrbiró, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
June 4, 2020
The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology
Inge M C M de Kok, Emily A Burger, Steffie K Naber, et al.
Journal of the National Cancer Institute
|
January 19, 2023
Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study
Rebecca Landy, Gregory Haber, Barry I Graubard, et al.
Gynecologic Oncology
|
July 30, 2020
Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions
Kate T Simms, Susan Yuill, James Killen, et al.
BMC Medicine
|
August 27, 2023
Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis
Kiesha Prem, Yoon Hong Choi, Élodie Bénard, et al.
Journal of Medical Screening
|
March 18, 2021
Impact of COVID-19-related care disruptions on cervical cancer screening in the United States
Emily A Burger, Erik El Jansen, James Killen, et al.
Preventive Medicine
|
May 24, 2021
Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis
Megan A Smith, Emily A Burger, Alejandra Castanon, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Preventive Medicine
|
March 8, 2021
Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis
Allison Portnoy, Kine Pedersen, Lill Trogstad, et al.
Journal of the National Cancer Institute
|
February 6, 2025
Impact of screening for human papillomavirus-positive oropharyngeal cancers: a microsimulation-based modeling study
Rebecca Landy, Gregory W Haber, Barry I Graubard, et al.
The Lancet. Oncology
|
June 2, 2019
Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact
Danielle Rodin, Emily A Burger, Rifat Atun, et al.
International Journal of Cancer
|
December 19, 2025
Cost-effectiveness of low-dose CT lung cancer screening among individuals that have ever smoked in Norway: A model-based analysis using NELSON trial criteria and outcomes
Yancy S Wu, Natalia Kunst, Dávid M Győrbiró, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
June 4, 2020
The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology
Inge M C M de Kok, Emily A Burger, Steffie K Naber, et al.
Journal of the National Cancer Institute
|
January 19, 2023
Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study
Rebecca Landy, Gregory Haber, Barry I Graubard, et al.
Gynecologic Oncology
|
July 30, 2020
Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions
Kate T Simms, Susan Yuill, James Killen, et al.
BMC Medicine
|
August 27, 2023
Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis
Kiesha Prem, Yoon Hong Choi, Élodie Bénard, et al.
Journal of Medical Screening
|
March 18, 2021
Impact of COVID-19-related care disruptions on cervical cancer screening in the United States
Emily A Burger, Erik El Jansen, James Killen, et al.
Preventive Medicine
|
May 24, 2021
Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis
Megan A Smith, Emily A Burger, Alejandra Castanon, et al.
Page
of 7